Furosemide/triheptanoinVarious toxicities following off-label use: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1899卷 / 1期

关键词：

D O I：

10.1007/s40278-022-12170-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：196 / 196

相关论文

共 50 条

[41] DexmedetomidineVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2020, 1786 (1) : 75 - 75
[42] AnakinraVarious toxicities following off-label use: 16 case reports
Reactions Weekly, 2015, 1546 (1) : 25 - 25
[43] RituximabVarious toxicities and off-label use: 2 case reports
Reactions Weekly, 2019, 1739 (1) : 223 - 223
[44] ImmunosuppressantsVarious toxicities and off-label use: 2 case reports
Reactions Weekly, 2022, 1935 (1) : 225 - 225
[45] Ibritumomab-tiuxetanVarious toxicities following off-label use: 2 case reports
Reactions Weekly, 2022, 1932 (1) : 304 - 304
[46] BuprenorphineVarious toxicities following off-label treatment: 2 case reports
Reactions Weekly, 2020, 1832 (1) : 81 - 81
[47] DenosumabVarious toxicities following off-label treatment: 2 case reports
Reactions Weekly, 2019, 1781 (1) : 136 - 136
[48] Furosemide/methylprednisoloneRebound effect in the form of hypercalcaemia following off-label use: 2 case reports
Reactions Weekly, 2023, 1943 (1) : 325 - 325
[49] DisulfiramVarious toxicities and no improvement following off-label use: 47 case reports
Reactions Weekly, 2021, 1873 (1) : 104 - 104
[50] BevacizumabVarious toxicities following off-label use of bevacizumab: 5 case reports
Reactions Weekly, 2023, 1981 (1) : 90 - 90

← 1 2 3 4 5 →